LockBit Claims Massive Breach of Federal Reserve: 33TB Databy Lilu Anderson 25.06.2024"LockBit claims a massive 33TB data breach of the U.S. Federal Reserve, casting doubts as cybersecurity experts question the credibility ...
India’s SEBI Targets Stock Derivatives, Influencer Rulesby Mark Eisenberg 25.06.2024"SEBI plans new rules to curb market manipulation, enhance safety in stock derivatives, regulate financial influencers, and simplify delisting procedures."
Unlock Rewards and Secure Network with FaceDAO Stakingby John Darbie 25.06.2024Secure FaceDAO Staking: Learn how to stake FaceDAO and earn rewards with this step-by-step guide for beginners. Start your staking ...
White House Rehires Balanced Crypto Adviser for Cybersecurity Roleby John Darbie 25.06.2024"White House rehires Carole House as Special Advisor for Cybersecurity. Her expertise will shape secure, innovative digital finance policies."
David Kain on CDK Global: Cyberattack Lessons for Dealershipsby Lilu Anderson 25.06.2024David Kain on CDK Cyberattack: Learn from the recent attack's key insights on fortified cybersecurity and robust contingency planning for ...
Brazil Stocks Climb: Bovespa Index Gains 1.07%by Mark Eisenberg 25.06.2024"Brazil Stocks Rally with Bovespa Up 1.07%; Top Gainers Include Magazine Luiza, MRV Engenharia. Market Stability Evident as Volatility Drops."
Hedge Funds Exit Bitcoin & Short MicroStrategy: Insightsby John Darbie 25.06.2024Peter Schiff warns hedge funds are selling Bitcoin and shorting MicroStrategy, signaling a shift in strategy that could impact market ...
Binance CEO: Bitcoin to Surpass $80K by 2025; Solana & BNB to Riseby John Darbie 25.06.2024Binance CEO predicts Bitcoin will hit $80K by 2025, sparking interest in altcoins like Solana, Rollblock, and Binance Coin as ...
Bitcoin’s Sell in May Phase & New ETFs: Key Insightsby John Darbie 25.06.2024"Analyst Mark Wong discusses Bitcoin's potential 'Sell in May' phase, market trends, ETF outflows, and future prospects amid market volatility."
CTT Pharma CEO Buys $70 in Stock, Owns 5M+ Sharesby Mark Eisenberg 25.06.2024CTT Pharmaceutical CEO buys $70 in stock, signaling confidence. Despite recent gains, profitability concerns remain. Investors should monitor closely.